Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

STRD vs SMLR

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
STRD
MicroStrategy Incorporated 10.00% Series A Perpetual Stride Preferred Stock

Financial - Capital Markets

Financial ServicesNASDAQ • US
Market Cap$22.29B
5Y Perf.-15.0%
SMLR
Semler Scientific, Inc.

Medical - Devices

HealthcareNASDAQ • US
Market Cap$311M
5Y Perf.-60.5%

STRD vs SMLR — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
STRD logoSTRD
SMLR logoSMLR
IndustryFinancial - Capital MarketsMedical - Devices
Market Cap$22.29B$311M
Revenue (TTM)$477M$37M
Net Income (TTM)$-3.85B$48M
Gross Margin68.7%90.8%
Operating Margin-11.4%-94.7%
Forward P/E1.4x4.0x
Total Debt$8.24B$70K
Cash & Equiv.$2.30B$9M

STRD vs SMLRLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

STRD
SMLR
StockJun 25May 26Return
MicroStrategy Incor… (STRD)10085.0-15.0%
Semler Scientific, … (SMLR)10039.5-60.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: STRD vs SMLR

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: STRD leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Semler Scientific, Inc. is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
STRD
MicroStrategy Incorporated 10.00% Series A Perpetual Stride Preferred Stock
The Banking Pick

STRD carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • beta 0.87
  • Rev growth 3.0%, EPS growth -151.3%
  • Lower volatility, beta 0.87, Low D/E 16.1%, current ratio 5.62x
Best for: income & stability and growth exposure
SMLR
Semler Scientific, Inc.
The Long-Run Compounder

SMLR is the clearest fit if your priority is long-term compounding.

  • 11.1% 10Y total return vs STRD's -1.9%
  • 130.8% margin vs STRD's -8.1%
  • 8.1% ROA vs STRD's -6.3%, ROIC 13.3% vs -9.6%
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthSTRD logoSTRD3.0% NII/revenue growth vs SMLR's -17.4%
ValueSTRD logoSTRDLower P/E (1.4x vs 4.0x)
Quality / MarginsSMLR logoSMLR130.8% margin vs STRD's -8.1%
Stability / SafetySTRD logoSTRDBeta 0.87 vs SMLR's 2.48
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)STRD logoSTRD-1.9% vs SMLR's -38.5%
Efficiency (ROA)SMLR logoSMLR8.1% ROA vs STRD's -6.3%, ROIC 13.3% vs -9.6%

STRD vs SMLR — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLSTRDLAGGINGSMLR

Income & Cash Flow (Last 12 Months)

SMLR leads this category, winning 4 of 4 comparable metrics.

STRD is the larger business by revenue, generating $477M annually — 12.9x SMLR's $37M. SMLR is the more profitable business, keeping 130.8% of every revenue dollar as net income compared to STRD's -8.1%.

MetricSTRD logoSTRDMicroStrategy Inc…SMLR logoSMLRSemler Scientific…
RevenueTrailing 12 months$477M$37M
EBITDAEarnings before interest/tax-$9.3B-$35M
Net IncomeAfter-tax profit-$3.8B$48M
Free Cash FlowCash after capex-$46M-$389M
Gross MarginGross profit ÷ Revenue+68.7%+90.8%
Operating MarginEBIT ÷ Revenue-11.4%-94.7%
Net MarginNet income ÷ Revenue-8.1%+130.8%
FCF MarginFCF ÷ Revenue-10.5%
Rev. Growth (YoY)Latest quarter vs prior year-44.6%
EPS Growth (YoY)Latest quarter vs prior year-13.2%+48.6%
SMLR leads this category, winning 4 of 4 comparable metrics.

Valuation Metrics

STRD leads this category, winning 2 of 3 comparable metrics.
MetricSTRD logoSTRDMicroStrategy Inc…SMLR logoSMLRSemler Scientific…
Market CapShares × price$22.3B$311M
Enterprise ValueMkt cap + debt − cash$28.2B$302M
Trailing P/EPrice ÷ TTM EPS-4.98x3.96x
Forward P/EPrice ÷ next-FY EPS est.1.45x
PEG RatioP/E ÷ EPS growth rate0.18x
EV / EBITDAEnterprise value multiple14.04x
Price / SalesMarket cap ÷ Revenue46.71x5.52x
Price / BookPrice ÷ Book value/share0.41x0.70x
Price / FCFMarket cap ÷ FCF
STRD leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

SMLR leads this category, winning 9 of 9 comparable metrics.

SMLR delivers a 10.5% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-8 for STRD. SMLR carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to STRD's 0.16x. On the Piotroski fundamental quality scale (0–9), SMLR scores 4/9 vs STRD's 3/9, reflecting mixed financial health.

MetricSTRD logoSTRDMicroStrategy Inc…SMLR logoSMLRSemler Scientific…
ROE (TTM)Return on equity-8.0%+10.5%
ROA (TTM)Return on assets-6.3%+8.1%
ROICReturn on invested capital-9.6%+13.3%
ROCEReturn on capital employed-12.6%+13.7%
Piotroski ScoreFundamental quality 0–934
Debt / EquityFinancial leverage0.16x0.00x
Net DebtTotal debt minus cash$5.9B-$9M
Cash & Equiv.Liquid assets$2.3B$9M
Total DebtShort + long-term debt$8.2B$70,000
Interest CoverageEBIT ÷ Interest expense-39.91x-12.85x
SMLR leads this category, winning 9 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

STRD leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in STRD five years ago would be worth $9,810 today (with dividends reinvested), compared to $1,815 for SMLR. Over the past 12 months, STRD leads with a -1.9% total return vs SMLR's -38.5%. The 3-year compound annual growth rate (CAGR) favors STRD at -0.6% vs SMLR's -6.8% — a key indicator of consistent wealth creation.

MetricSTRD logoSTRDMicroStrategy Inc…SMLR logoSMLRSemler Scientific…
YTD ReturnYear-to-date+3.6%+14.3%
1-Year ReturnPast 12 months-1.9%-38.5%
3-Year ReturnCumulative with dividends-1.9%-18.9%
5-Year ReturnCumulative with dividends-1.9%-81.8%
10-Year ReturnCumulative with dividends-1.9%+1110.1%
CAGR (3Y)Annualised 3-year return-0.6%-6.8%
STRD leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

STRD leads this category, winning 2 of 2 comparable metrics.

STRD is the less volatile stock with a 0.87 beta — it tends to amplify market swings less than SMLR's 2.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. STRD currently trades 78.3% from its 52-week high vs SMLR's 40.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSTRD logoSTRDMicroStrategy Inc…SMLR logoSMLRSemler Scientific…
Beta (5Y)Sensitivity to S&P 5000.85x2.35x
52-Week HighHighest price in past year$96.81$50.44
52-Week LowLowest price in past year$64.17$14.88
% of 52W HighCurrent price vs 52-week peak+78.3%+40.3%
RSI (14)Momentum oscillator 0–10047.652.4
Avg Volume (50D)Average daily shares traded92K0
STRD leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.
MetricSTRD logoSTRDMicroStrategy Inc…SMLR logoSMLRSemler Scientific…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$50.50
# AnalystsCovering analysts7
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

STRD leads in 3 of 6 categories (Valuation Metrics, Total Returns). SMLR leads in 2 (Income & Cash Flow, Profitability & Efficiency).

Best OverallMicroStrategy Incorporated … (STRD)Leads 3 of 6 categories
Loading custom metrics...

STRD vs SMLR: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is STRD or SMLR a better buy right now?

For growth investors, MicroStrategy Incorporated 10.

00% Series A Perpetual Stride Preferred Stock (STRD) is the stronger pick with 3. 0% revenue growth year-over-year, versus -17. 4% for Semler Scientific, Inc. (SMLR). Semler Scientific, Inc. (SMLR) offers the better valuation at 4. 0x trailing P/E, making it the more compelling value choice. Analysts rate Semler Scientific, Inc. (SMLR) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — STRD or SMLR?

Over the past 5 years, MicroStrategy Incorporated 10.

00% Series A Perpetual Stride Preferred Stock (STRD) delivered a total return of -1. 9%, compared to -81. 8% for Semler Scientific, Inc. (SMLR). Over 10 years, the gap is even starker: SMLR returned +1110% versus STRD's -1. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — STRD or SMLR?

By beta (market sensitivity over 5 years), MicroStrategy Incorporated 10.

00% Series A Perpetual Stride Preferred Stock (STRD) is the lower-risk stock at 0. 85β versus Semler Scientific, Inc. 's 2. 35β — meaning SMLR is approximately 177% more volatile than STRD relative to the S&P 500. On balance sheet safety, Semler Scientific, Inc. (SMLR) carries a lower debt/equity ratio of 0% versus 16% for MicroStrategy Incorporated 10. 00% Series A Perpetual Stride Preferred Stock — giving it more financial flexibility in a downturn.

04

Which is growing faster — STRD or SMLR?

By revenue growth (latest reported year), MicroStrategy Incorporated 10.

00% Series A Perpetual Stride Preferred Stock (STRD) is pulling ahead at 3. 0% versus -17. 4% for Semler Scientific, Inc. (SMLR). On earnings-per-share growth, the picture is similar: Semler Scientific, Inc. grew EPS 95. 1% year-over-year, compared to -151. 3% for MicroStrategy Incorporated 10. 00% Series A Perpetual Stride Preferred Stock. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — STRD or SMLR?

Semler Scientific, Inc.

(SMLR) is the more profitable company, earning 72. 7% net margin versus -806. 3% for MicroStrategy Incorporated 10. 00% Series A Perpetual Stride Preferred Stock — meaning it keeps 72. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SMLR leads at 37. 2% versus -1140. 8% for STRD. At the gross margin level — before operating expenses — SMLR leads at 91. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — STRD or SMLR?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is STRD or SMLR better for a retirement portfolio?

For long-horizon retirement investors, MicroStrategy Incorporated 10.

00% Series A Perpetual Stride Preferred Stock (STRD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 85)). Semler Scientific, Inc. (SMLR) carries a higher beta of 2. 35 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (STRD: -1. 3%, SMLR: +1110%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between STRD and SMLR?

These companies operate in different sectors (STRD (Financial Services) and SMLR (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: STRD is a mid-cap quality compounder stock; SMLR is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

STRD

Quality Business

  • Sector: Financial Services
  • Market Cap > $100B
  • Gross Margin > 41%
Run This Screen
Stocks Like

SMLR

Quality Mega-Cap Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 78%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform STRD and SMLR on the metrics below

Revenue Growth>
%
(STRD: 3.0% · SMLR: -44.6%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.